2010 News
- 12/21/10
- Dr. Mitchell Karl to Join Vicor Technologies’ Scientific Advisory Board and Serve as Associate Medical Director
- 12/16/10
- Vicor Technologies Announces Exclusive Distributorship for its PD2i® Products in the People’s Republic of China, Hong Kong, and Macau
- 12/15/10
- Vicor Technologies Names Dr. Edward Lundy Chairman of its Scientific Advisory Board
- 12/14/10
- Vicor Technologies Announces Sales of PD2i Analyzer™ in Six New States
- 11/16/10
- Vicor Technologies Announces New Directors
- 11/9/10
- Vicor Technologies to Present at Life Tech Capital’s First Annual Miami Medical Investors Conference
- 11/2/10
- Vicor Technologies Powers U.S. Sales Efforts for its PD2i Analyzer™ with New Independent Sales Representatives in Territories Nationwide
- 10/26/10
- Vicor Technologies Receives Institutional Review Board Approval for Study to Assess Concussion in NCAA Athletes Using its PD2i Analyzer™
- 10/20/10
- Vicor Technologies Issued United States Patent Related to its State Dependent Drug Development Platform
- 10/12/10
- Vicor Technologies Announces Sale of Convertible Notes and Warrants
- 10/6/10
- Vicor Technologies Selects Dell to Serve as Worldwide IT Hardware Partner for itsPD2i Analyzer™
- 9/28/10
- Vicor Technologies Receives Institutional Review Board Approval for Study to Identify Normal Ranges for PD2i® Values Obtained from Tests Performed with its PD2i Analyzer™
- 9/22/10
- Vicor Technologies’ CEO David Fater Interviewed for The Wall Street Transcript Medical Devices Report
- 9/14/10
- Vicor Technologies Names Christopher Vissman National Sales Manager
- 8/26/10
- Vicor Technologies Announces Abstracts of PD2i® Studies Accepted for Presentation at Poster Session of 2010 Heart-Brain Summit
- 8/19/10
- Vicor Technologies Trains Technicians, Initiates Data Collection Using PD2i® Nonlinear Algorithm for London-Based Cardiac Risk in the Young Initiative
- 7/28/10
- Vicor Technologies’ Chief Medical Officer to Present Abstract on Hypovolemia Study Results at the AABB 2010 Annual Meeting
- 7/1/10
- Vicor Technologies Submits 510(k) Application to FDA for Cardiac Marketing Claim
- 6/22/10
- Vicor Technologies to Present at Sidoti & Company Seminannual New York Micro-Cap Conference
- 6/2/10
- Vicor Technologies to Present at Noble Financial 2010 Equity Conference
- 5/19/10
- Vicor Technologies Announces Results of PD2i® Analysis of MUSIC Trial Data
- 5/04/10
- Vicor Technologies Receives Allowance of United States Patent Application Related to its State Dependent Drug Development Platform
- 4/20/10
- Vicor Technologies Announces Results of Pilot Study of its PD2i® Nonlinear Algorithm to Detect Acute Hypovolemia
- 4/08/10
- Vicor Technologies CEO David Fater Discusses Company’s Product Commercialization Status with Shareholder Vision in Exclusive Video Interview
- 3/17/10
- Vicor Technologies Submits Analysis of MUSIC Trial Dataset to University of Rochester for Final Determination of Results
- 2/23/10
- Vicor Technologies Announces Extensive Collaborative Agreement with the Universidad San Francisco de Quito in Ecuador
- 1/14/10
- Vicor Technologies Announces Exclusive Distribution Agreement for its PD2i Analyzer™ and First U.S. Physician Sale
- 1/5/10
- Vicor Technologies Forms Information Technology Function With Two Senior Hires; New Function To Support Staged Product Rollout Beginning January 2010
